News-Medical.Net on MSN
Understanding thrombocytopenia in patients with portal hypertension and chronic liver disease
Chronic liver disease (CLD) and its advanced stage, cirrhosis, represent a significant global health burden, with portal ...
The FDA on May 21 approved Dova Pharmaceuticals’ drug Doptelet to treat thrombocytopenia — a condition involving a low blood platelet count — in chronic liver disease patients set to undergo a medical ...
Among more than 2,300 patients with advanced chronic liver disease, a six-parameter algorithm, known as PLEASE, indicated that patients stratified as high risk had a cumulative risk of developing de ...
Please provide your email address to receive an email when new articles are posted on . In 2023, nearly a third of hospitalized patients with chronic liver disease had acute kidney injury or ...
In 1980, Ludwig and colleagues described the histologic features of a newly identified chronic liver condition referred to as nonalcoholic steatohepatitis (NASH) and noted that the majority of the ...
Intercept Pharmaceuticals has pulled obeticholic acid (Ocaliva) from the U.S. market as a treatment for primary biliary cholangitis (PBC) after the FDA requested its removal and placed ongoing trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback